JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Raja M. Flores
Harvey I. Pass
Manjit S. Bains
Valerie W. Rusch
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flores, R. M.
Right arrow Articles by Rusch, V. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Flores, R. M.
Right arrow Articles by Rusch, V. W.
Related Collections
Right arrow Lung - cancer
Right arrow Pleura

J Thorac Cardiovasc Surg 2008;135:620-626
© 2008 The American Association for Thoracic Surgery


General Thoracic Surgery

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients

Raja M. Flores, MDa,*, Harvey I. Pass, MDd, Venkatraman E. Seshan, PhDb, Joseph Dycoco, BAa, Maureen Zakowski, MDc, Michele Carbone, MDe, Manjit S. Bains, MDa, Valerie W. Rusch, MDa

a Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
b Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY
c Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY
d Department of Cardiothoracic Surgery, New York University Medical Center, New York, NY
e Department of Pathology, University of Hawaii, Honolulu, Hawaii

Received for publication May 3, 2007; revisions received September 13, 2007; accepted for publication October 22, 2007.

* Address for reprints: Raja M. Flores, MD, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room C-879, New York, NY 10021. (Email: floresr{at}mskcc.org).

Objective: The optimal procedure for resection of malignant pleural mesothelioma is controversial, partly because previous analyses include small numbers of patients. We performed a multi-institutional study to increase statistical power to detect significant differences in outcome between extrapleural pneumonectomy and pleurectomy/decortication.

Methods: Patients with malignant pleural mesothelioma who underwent extrapleural pneumonectomy or pleurectomy/decortication at 3 institutions were identified. Survival and prognostic factors were analyzed by the Kaplan–Meier method, log-rank test, and Cox proportional hazards analysis.

Results: From 1990 to 2006, 663 consecutive patients (538 men and 125 women) underwent resection. The median age was 63 years (range, 26–93 years). The operative mortality was 7% for extrapleural pneumonectomy (n = 27/385) and 4% for pleurectomy/decortication (n = 13/278). Significant survival differences were seen for American Joint Committee on Cancer stages 1 to 4 (P < .001), epithelioid versus non-epithelioid histology (P < .001), extrapleural pneumonectomy versus pleurectomy/decortication (P < .001), multimodality therapy versus surgery alone (P < .001), and gender (P < .001). Multivariate analysis demonstrated a hazard rate of 1.4 for extrapleural pneumonectomy (P < .001) controlling for stage, histology, gender, and multimodality therapy.

Conclusion: Patients who underwent pleurectomy/decortication had a better survival than those who underwent extrapleural pneumonectomy; however, the reasons are multifactorial and subject to selection bias. At present, the choice of resection should be tailored to the extent of disease, patient comorbidities, and type of multimodality therapy planned.



Abbreviations and Acronyms EPP = extrapleural pneumonectomy; MPM = malignant pleural mesothelioma; P/D = pleurectomy/decortication





This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
M. Shimokawa, S. Hasegawa, K. Fukuoka, M. Okada, K. Yokoi, F. Tanaka, T. Yamanaka, T. Daimon, and T. Nakano
A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Pleurectomy/Decortication Aimed at Macroscopic Complete Resection for Malignant Pleural Mesothelioma
Jpn. J. Clin. Oncol., May 1, 2013; 43(5): 575 - 578.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
Y. Tsutani, T. Takuwa, Y. Miyata, K. Fukuoka, S. Hasegawa, T. Nakano, and M. Okada
Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma
Ann. Onc., April 1, 2013; 24(4): 1005 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Ried, T. Potzger, N. Braune, R. Neu, Y. Zausig, B. Schalke, C. Diez, and H.-S. Hofmann
Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience
Eur J Cardiothorac Surg, April 1, 2013; 43(4): 801 - 807.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
S. M. Gelvez-Zapata, D. Gaffney, M. Scarci, and A. S. Coonar
What is the survival after surgery for localized malignant pleural mesothelioma?
Interact CardioVasc Thorac Surg, April 1, 2013; 16(4): 533 - 537.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
J. Lindenmann, V. Matzi, N. Neuboeck, U. Anegg, A. Maier, J. Smolle, and F. M. Smolle-Juettner
Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
Interact CardioVasc Thorac Surg, March 1, 2013; 16(3): 237 - 243.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
D. A. Waller
Lung-sparing total pleurectomy: the surgical option of choice in malignant pleural mesothelioma?
Eur J Cardiothorac Surg, February 7, 2013; (2013) ezt022v1.
[Full Text] [PDF]


Home page
Asian Cardiovascular and Thoracic AnnalsHome page
T. Ploenes, T. Osei-Agyemang, A. Krohn, C. F. Waller, V. Duncker-Rohr, M. Elze, and B. Passlick
Changes in lung function after surgery for mesothelioma
Asian Cardiovascular and Thoracic Annals, February 1, 2013; 21(1): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. Bolukbas, M. Eberlein, N. Kudelin, M. Demes, S. Stallmann, A. Fisseler-Eckhoff, and J. Schirren
Factors predicting poor survival after lung-sparing radical pleurectomy of IMIG stage III malignant pleural mesothelioma
Eur J Cardiothorac Surg, December 13, 2012; (2012) ezs648v1.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
G. PASELLO, G. MARULLI, V. POLO, C. BREDA, L. BONANNO, L. LOREGGIAN, F. REA, and A. FAVARETTO
Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
Anticancer Res, December 1, 2012; 32(12): 5393 - 5399.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. M. Mollberg, Y. Vigneswaran, H. L. Kindler, C. Warnes, R. Salgia, A. N. Husain, and W. T. Vigneswaran
Quality of Life After Radical Pleurectomy Decortication for Malignant Pleural Mesothelioma
Ann. Thorac. Surg., October 1, 2012; 94(4): 1086 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovascular and Thoracic AnnalsHome page
B. S. Al-Alao, H. Parissis, I. J. Rychlik, A. Graham, and J. McGuigan
Prognostic factors in malignant pleural mesothelioma: role of talc pleurodesis
Asian Cardiovascular and Thoracic Annals, August 1, 2012; 20(4): 443 - 449.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
A. Bille, L. Okiror, W. Karenovics, J. Pilling, and L. Lang-Lazdunski
What is the optimum strategy for thromboembolic prophylaxis following extrapleural pneumonectomy in patients with malignant pleural mesothelioma?
Interact CardioVasc Thorac Surg, August 1, 2012; 15(2): 201 - 203.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
L. Lang-Lazdunski, S. Barrington, A. Bille, and P.-Y. Bondiau
Cyberknife radiosurgery for focal paravertebral recurrence after radical pleurectomy/decortication in malignant pleural mesothelioma
Eur J Cardiothorac Surg, June 1, 2012; 41(6): 1393 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. S. Friedberg, M. J. Culligan, R. Mick, J. Stevenson, S. M. Hahn, D. Sterman, S. Punekar, E. Glatstein, and K. Cengel
Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma
Ann. Thorac. Surg., May 1, 2012; 93(5): 1658 - 1667.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
A. Nakas, E. v. Meyenfeldt, K. Lau, S. Muller, and D. Waller
Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma
Eur J Cardiothorac Surg, May 1, 2012; 41(5): 1031 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
S. E. Chen and M. B. Pace
Malignant pleural mesothelioma
Am. J. Health Syst. Pharm., March 1, 2012; 69(5): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
M. Hoffmann, A. Ulrich, E. Schloericke, S. Limmer, J. K. Habermann, H. Wolken, H.-P. Bruch, and P. Kujath
The application of cold-plasma coagulation on the visceral pleura results in a predictable depth of necrosis without fistula generation
Interact CardioVasc Thorac Surg, March 1, 2012; 14(3): 239 - 243.
[Abstract] [Full Text] [PDF]


Home page
J Natl Compr Canc NetwHome page
D. S. Ettinger, W. Akerley, H. Borghaei, A. Chang, R. T. Cheney, L. R. Chirieac, T. A. D'Amico, T. L. Demmy, A. K. P. Ganti, R. Govindan, et al.
Malignant Pleural Mesothelioma
J Natl Compr Canc Netw, January 1, 2012; 10(1): 26 - 41.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. D. Schulz, K. A. V. Zubris, J. E. Wade, R. F. Padera, X. Xu, M. W. Grinstaff, and Y. L. Colson
Paclitaxel-Loaded Expansile Nanoparticles in a Multimodal Treatment Model of Malignant Mesothelioma
Ann. Thorac. Surg., December 1, 2011; 92(6): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
G. Dimitrakakis, T. BinEsmael, A. Szafranek, and P. A. O'Keefe
ERRATUM for a missing eComment 'Malignant pleural mesothelioma: a therapeutic challenge'
Interact CardioVasc Thorac Surg, December 1, 2011; 13(6): 691 - 692.
[Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
T. Tokunaga, M. Higashiyama, J. Okami, J. Maeda, A. Fujiwara, and K. Kodama
ERRATUM for a missing eComment to 'Intrathoracic chemo-thermotherapy with radiofrequency waves after extrapleural pneumonectomy for malignant pleural mesothelioma': [Interact CardioVasc Thorac Surg 2011;13:267-270]
Interact CardioVasc Thorac Surg, October 1, 2011; 13(4): 460 - 461.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Carbone, Y. I. Baris, P. Bertino, B. Brass, S. Comertpay, A. U. Dogan, G. Gaudino, S. Jube, S. Kanodia, C. R. Partridge, et al.
Erionite exposure in North Dakota and Turkish villages with mesothelioma
PNAS, August 16, 2011; 108(33): 13618 - 13623.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. S. Friedberg, R. Mick, M. Culligan, J. Stevenson, A. Fernandes, D. Smith, E. Glatstein, S. M. Hahn, and K. Cengel
Photodynamic Therapy and the Evolution of a Lung-Sparing Surgical Treatment for Mesothelioma
Ann. Thorac. Surg., June 1, 2011; 91(6): 1738 - 1745.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
S. Sharif, I. Zahid, T. Routledge, and M. Scarci
Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 1040 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Genes & CancerHome page
M. Nasu, M. Carbone, G. Gaudino, B. H. Ly, P. Bertino, D. Shimizu, P. Morris, H. I. Pass, and H. Yang
Ranpirnase Interferes with NF-{kappa}B Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth
Genes & Cancer, May 1, 2011; 2(5): 576 - 584.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
I. Zahid, S. Sharif, T. Routledge, and M. Scarci
Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
Interact CardioVasc Thorac Surg, May 1, 2011; 12(5): 812 - 817.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
O. Rena and C. Casadio
Lack of evidence in malignant pleural mesothelioma surgery
Interact CardioVasc Thorac Surg, March 1, 2011; 12(3): 347 - 348.
[Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
Y. Shahin, J. Wellham, R. Jappie, K. Pointon, A. Majewski, and E. Black
How successful is lung-preserving radical surgery in the mesothelioma and radical surgery-trial environment? A case-controlled analysis
Eur J Cardiothorac Surg, March 1, 2011; 39(3): 360 - 363.
[Abstract] [Full Text] [PDF]


Home page
J R Soc MedHome page
E. Teh, F. Fiorentino, C. Tan, and T. Treasure
A systematic review of lung-sparing extirpative surgery for pleural mesothelioma
Journal of the Royal Society of Medicine, February 1, 2011; 104(2): 69 - 80.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. B. Watzka, U. Setinek, E. B. Stubenberger, M. Totsch, G. Dekan, M. Marcher, T. Fleck, and M. R. Muller
Integrin-linked kinase, phosphorylated AKT and the prognosis of malignant pleural mesothelioma
Eur J Cardiothorac Surg, February 1, 2011; 39(2): 180 - 184.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
K. Kawamukai, F. Antonacci, S. Di Saverio, and M. Boaron
Acute postoperative cardiac herniation
Interact CardioVasc Thorac Surg, January 1, 2011; 12(1): 73 - 74.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. E. Van Schil, P. Baas, R. Gaafar, A. P. Maat, M. Van de Pol, B. Hasan, H. M. Klomp, A. M. Abdelrahman, J. Welch, J. P. van Meerbeeck, et al.
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial
Eur. Respir. J., December 1, 2010; 36(6): 1362 - 1369.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
W. Weder
Mesothelioma
Ann. Onc., October 1, 2010; 21(suppl_7): vii326 - vii333.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. S. Wolf, W. G. Richards, T. R. Tilleman, L. Chirieac, S. Hurwitz, R. Bueno, and D. J. Sugarbaker
Characteristics of Malignant Pleural Mesothelioma in Women
Ann. Thorac. Surg., September 1, 2010; 90(3): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Creaney, N. J. Olsen, F. Brims, I. M. Dick, A. W. Musk, N. H. de Klerk, S. J. Skates, and B. W. S. Robinson
Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
Cancer Epidemiol. Biomarkers Prev., September 1, 2010; 19(9): 2238 - 2246.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
M. Utley, F. Fiorentino, and T. Treasure
Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma,
Eur J Cardiothorac Surg, September 1, 2010; 38(3): 241 - 244.
[Abstract] [Full Text] [PDF]


Home page
Thoracic MalignanciesHome page
W. Weder, I. Opitz, and R. Stahel
Surgery and multimodality treatment for malignant pleural mesothelioma
Thoracic Malignancies, June 10, 2010; 407 - 418.
[Abstract] [Fulltext] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
M. Hoffmann, H.-P. Bruch, P. Kujath, and S. Limmer
Cold-plasma coagulation in the treatment of malignant pleural mesothelioma: results of a combined approach
Interact CardioVasc Thorac Surg, April 1, 2010; 10(4): 502 - 505.
[Abstract] [Full Text] [PDF]


Home page
Interact CardioVasc Thorac SurgHome page
M. Lucchi, A. Picchi, G. Ali, A. Chella, G. Guglielmi, A. Cristaudo, G. Fontanini, and A. Mussi
Multimodality treatment of malignant pleural mesothelioma with or without immunotherapy: does it change anything?
Interact CardioVasc Thorac Surg, April 1, 2010; 10(4): 572 - 576.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Balduyck, D. Trousse, A. Nakas, A. E. Martin-Ucar, J. Edwards, and D. A. Waller
Therapeutic Surgery for Nonepithelioid Malignant Pleural Mesothelioma: Is it Really Worthwhile?
Ann. Thorac. Surg., March 1, 2010; 89(3): 907 - 911.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
T. Treasure
Surgery for mesothelioma: MARS landing and future missions
Eur J Cardiothorac Surg, March 1, 2010; 37(3): 509 - 510.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Rice
Invited Commentary
Ann. Thorac. Surg., January 1, 2010; 89(1): 210 - 211.
[Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
D. S. Trousse, J.-P. Avaro, X. B. D'Journo, C. Doddoli, P. Astoul, R. Giudicelli, P. A. Fuentes, and P. A. Thomas
Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies
Eur J Cardiothorac Surg, October 1, 2009; 36(4): 759 - 763.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. C. Rice, M. A. Steliga, J. Stewart, G. Eapen, C. A. Jimenez, J. H. Lee, W. L. Hofstetter, E. M. Marom, R. J. Mehran, A. A. Vaporciyan, et al.
Endoscopic Ultrasound-Guided Fine Needle Aspiration for Staging of Malignant Pleural Mesothelioma
Ann. Thorac. Surg., September 1, 2009; 88(3): 862 - 869.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. P Currie, S. J Watt, and N. A Maskell
An overview of how asbestos exposure affects the lung
BMJ, August 24, 2009; 339(aug24_1): b3209 - b3209.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. R. Tilleman, W. G. Richards, L. Zellos, B. E. Johnson, M. T. Jaklitsch, J. Mueller, B. Y. Yeap, A. A. Mujoomdar, C. T. Ducko, R. Bueno, et al.
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
L. M. Krug, H. I. Pass, V. W. Rusch, H. L. Kindler, D. J. Sugarbaker, K. E. Rosenzweig, R. Flores, J. S. Friedberg, K. Pisters, M. Monberg, et al.
Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma
J. Clin. Oncol., June 20, 2009; 27(18): 3007 - 3013.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. J. Gordon, L. Dong, B. Y. Yeap, W. G. Richards, J. N. Glickman, H. Edenfield, M. Mani, R. Colquitt, G. Maulik, B. Van Oss, et al.
Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma
J Natl Cancer Inst, May 6, 2009; 101(9): 678 - 686.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. D. Yan, M. Boyer, M. M. Tin, J. Sim, C. Kennedy, J. McLean, P. G. Bannon, and B. C. McCaughan
Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural Mesothelioma
Ann. Thorac. Surg., May 1, 2009; 87(5): 1552 - 1556.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. S. Tsao, I. Wistuba, J. A. Roth, and H. L. Kindler
Malignant Pleural Mesothelioma
J. Clin. Oncol., April 20, 2009; 27(12): 2081 - 2090.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. de Perrot, R. Feld, B.C. J. Cho, A. Bezjak, M. Anraku, R. Burkes, H. Roberts, M. S. Tsao, N. Leighl, S. Keshavjee, et al.
Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma
J. Clin. Oncol., March 20, 2009; 27(9): 1413 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
L. Ampollini, A. Soltermann, E. Felley-Bosco, D. Lardinois, S. Arni, R. F. Speck, W. Weder, and I. Opitz
Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting
Eur J Cardiothorac Surg, March 1, 2009; 35(3): 457 - 462.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
A. Nakas, D. S. Trousse, A. E. Martin-Ucar, and D. A. Waller
Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy
Eur J Cardiothorac Surg, October 1, 2008; 34(4): 886 - 891.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.